Changes in myocardial iron content following administration of intravenous iron (Myocardial‐IRON): Study design

Treatment with intravenous ferric carboxymaltose (FCM) has been shown to improve symptoms, functional capacity, and quality of life in patients with heart failure and iron deficiency. However, the underlying mechanisms for these beneficial effects remain undetermined. The aim of this study is to qua...

Full description

Saved in:
Bibliographic Details
Published in:Clin Cardiol
Main Authors: Miñana, Gema, Cardells, Ingrid, Palau, Patricia, Llàcer, Pau, Fácila, Lorenzo, Almenar, Luis, López‐Lereu, Maria Pilar, Monmeneu, Jose V., Amiguet, Martina, González, Jessika, Serrano, Alicia, Montagud, Vicente, López‐Vilella, Raquel, Valero, Ernesto, García‐Blas, Sergio, Bodí, Vicent, de la Espriella‐Juan, Rafael, Sanchis, Juan, Chorro, Francisco J., Bayés‐Genís, Antoni, Núñez, Julio
Format: Artigo
Language:Inglês
Published: Wiley Periodicals, Inc. 2018
Subjects:
Trial Designs
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6489786/
https://ncbi.nlm.nih.gov/pubmed/29607528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22956
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items